SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-011910
Filing Date
2020-02-06
Accepted
2020-02-06 16:11:32
Documents
1
Period of Report
2020-02-04

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2380
  Complete submission text file 0001104659-20-011910.txt   4077
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR LE PRINCE DE GALLES 3-5 AVE DE CITRONNIE MONTE CARLO O9 98000
Business Address THC MANAGEMENT SERVICES S.A.M. 2ND FLOOR LE PRINCE DE GALLES 3-5 AVE DE CITRONNIE MONTE CARLO O9 98000 011 377 97 97 47 37
Equal Talent Investments Ltd (Reporting) CIK: 0001769229 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38542 | Film No.: 20582819